lactic acid has been researched along with Mucopolysaccharidosis I in 1 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salvalaio, M | 1 |
Rigon, L | 1 |
Belletti, D | 1 |
D'Avanzo, F | 1 |
Pederzoli, F | 1 |
Ruozi, B | 1 |
Marin, O | 1 |
Vandelli, MA | 1 |
Forni, F | 1 |
Scarpa, M | 1 |
Tomanin, R | 1 |
Tosi, G | 1 |
1 other study available for lactic acid and Mucopolysaccharidosis I
Article | Year |
---|---|
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
Topics: Albumins; Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Carriers; Enzyme Replacement Th | 2016 |